Advertisement

Pediatric Surgery International

, Volume 33, Issue 9, pp 955–959 | Cite as

Surgical management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed

  • Tianyou Yang
  • Yongbo Huang
  • Tao Xu
  • Tianbao Tan
  • Jiliang Yang
  • Jing Pan
  • Chao Hu
  • Jiahao Li
  • Yan ZouEmail author
Original Article

Abstract

Purpose

Clinical researches about the management and outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed are limited. We report the surgical outcomes of ganglioneuroma and ganglioneuroblastoma-intermixed in a single institution.

Methods

Ganglioneuroma and ganglioneuroblastoma-intermixed diagnosed and resected between May 2009 and May 2015 in a tertiary children’s hospital were retrospectively reviewed. Patients’ demographic data, INSS stage, surgical complications, residual tumor size and outcomes were collected.

Results

Thirty-four patients were included in the current study. All had localized tumors and were surgically managed. The overall acute complications rates were 8.8% (3/34) and none were fatal. Thirty-three of 34 patients had at least macroscopic tumor resection. Six patients had radiographically detected residual tumor after surgery, 25 none and 3 undocumented. Thirty-three (97.1%) patients were alive during a median follow-up of 36 months (range 1–82). In subgroup analysis, no significant difference regarding surgical complications and survival was found between ganglioneuroma and ganglioneuroblastoma-intermixed. Increased complete resection rates were observed in thoracic tumor compared with abdominal ones (p = 0.03). However, no significant difference (p = 0.089) regarding overall survival was found between patients with residual tumors and those without. Of the six patients with residual tumors, three showed complete resolution, two were unchanged and one died 3 years after initial surgery (the only death in this study).

Conclusion

Ganglioneuroma and ganglioneuroblastoma-intermixed can be safely and effectively resected, the residual tumor seems not to influence overall survival.

Keywords

Neuroblastic tumor Ganglioneuroma Ganglioneuroblastoma Surgery 

Notes

Acknowledgements

This study was funded by the National natural science foundation of China (Grant Number 81602199), Guangzhou Science Technology and Innovation Commission (Grant Number 201607010395), Natural Science Foundation of Guangdong Province, China (Grant Number 2016A030313496).

Compliance with ethical standards

Conflict of interest

There are no conflicts of interest to declare. No honorarium, grant or other form of payment was given to anyone to produce the manuscript.

Ethics approval and consent to participate

This study was approved by the Institutional Review Board of Guangzhou Women and Children’s Medical Center (Guangzhou, China), which waived the need for informed consent for the retrospective collection of demographic, clinical and hospital outcome data. All patient records/data were anonymized and de-identified prior to analysis. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards

Consent for publication

All the authors have approved the manuscript and agree with submission to your esteemed journal.

References

  1. 1.
    Shimada H, Chatten J, Newton WA Jr et al (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405–416CrossRefPubMedGoogle Scholar
  2. 2.
    Shimada H, Ambros IM, Dehner LP et al (1999) Terminology and morphologic criteria of neuroblastic tumors—recommendations by the International Neuroblastoma Pathology Committee. Cancer 86:349–363CrossRefPubMedGoogle Scholar
  3. 3.
    Shimada H, Ambros IM, Dehner LP et al (1999) The International Neuroblastoma Pathology classification (the Shimada system). Cancer 86:364–372CrossRefPubMedGoogle Scholar
  4. 4.
    Ward E, DeSantis C, Robbins A et al (2014) Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64:83–103CrossRefPubMedGoogle Scholar
  5. 5.
    De Bernardi B, Gambini C, Haupt R et al (2008) Retrospective study of childhood ganglioneuroma. J Clin Oncol 26:1710–1716CrossRefPubMedGoogle Scholar
  6. 6.
    Retrosi G, Bishay M, Kiely EM et al (2011) Morbidity after ganglioneuroma excision: is surgery necessary? Eur J Pediatr Surg 21:33–37CrossRefPubMedGoogle Scholar
  7. 7.
    Sanchez-Galan A, Barrena S, Vilanova-Sanchez A et al (2014) Ganglioneuroma: to operate or not to operate. Eur J Pediatr Surg 24:25–30CrossRefPubMedGoogle Scholar
  8. 8.
    Decarolis B, Simon T, Krug B et al (2016) Treatment and outcome of ganglioneuroma and ganglioneuroblastoma intermixed. BMC Cancer 27:542. doi: 10.1186/s12885-016-2513-9 CrossRefGoogle Scholar
  9. 9.
    Geoerger B, Hero B, Harms D et al (2001) Metabolic activity and clinical features of primary ganglioneuromas. Cancer 91:1905–1913CrossRefPubMedGoogle Scholar
  10. 10.
    Akcakaya MO, Bilgic B, Aras Y, Izgi N (2015) A malignant transformation of a spinal epidural mass from ganglioneuroblastoma to neuroblastoma. J Korean Neurosurg Soc 57:211–214CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Kulkarni AV, Bilbao JM, Cusimano MD, Muller PJ (1998) Malignant transformation of ganglioneuroma into spinal neuroblastoma in an adult. J Neuro Surg 88:324–327Google Scholar
  12. 12.
    Nelms JK, Diner EK, Lack EE et al (2004) Retroperitoneal ganglioneuroma encasing the celiac and superior mesenteric arteries. Sci World J 4:974–977CrossRefGoogle Scholar
  13. 13.
    von Allmen D, Davidoff AM, London WB et al (2017) Impact of extent of resection on local control and survival in patients from the COG A3973 study with high-risk neuroblastoma. J Clin Oncol 35(2):208–216CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Tianyou Yang
    • 1
  • Yongbo Huang
    • 2
  • Tao Xu
    • 3
  • Tianbao Tan
    • 1
  • Jiliang Yang
    • 1
  • Jing Pan
    • 1
  • Chao Hu
    • 1
  • Jiahao Li
    • 1
  • Yan Zou
    • 1
    Email author
  1. 1.Department of Pediatric Surgery, Guangzhou Women and Children’s Medical CenterGuangzhou Medical UniversityGuangzhouChina
  2. 2.The First Affiliated Hospital of Guangzhou Medical UniversityGuangzhou Medical UniversityGuangzhouChina
  3. 3.Department of Hematology and Oncology, Guangzhou Women and Children’s Medical CenterGuangzhou Medical UniversityGuangzhouChina

Personalised recommendations